APA (7th ed.) Citation

A, M., M, S., U, B., M, S., & K, G. (2020). Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients. Dove Medical Press.

Chicago Style (17th ed.) Citation

A, Mehta, Saifi M, Batra U, Suryavanshi M, and Gupta K. Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients. Dove Medical Press, 2020.

MLA (8th ed.) Citation

A, Mehta, et al. Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients. Dove Medical Press, 2020.